Mostra 1 - 20 risultati di 35 ricerca '"Indonesia"', tempo di risposta: 0,12s Raffina i risultati
  1. 1
    “...BACKGROUND: Malaria remains a significant public health issue in Eastern Indonesia, where multidrug resistant Plasmodium falciparum and Plasmodium vivax are highly prevalent. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
  2. 2
    “...METHODS: A retrospective, hospital-based cohort study of infants aged 1–12 months with vivax malaria was carried out in Timika, Papua province, Indonesia. Risks of admission, death and severe haematological outcomes within 30 days of first presentation were compared between infants who did and did not receive primaquine. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
  3. 3
    “...We compared the platelet counts and clinical correlates of patients with and those without malaria in southern Papua, Indonesia. METHODS: Data were collated on patients presenting to a referral hospital between April 2004 and December 2012. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
  4. 4
    “...BACKGROUND: In southern Papua, Indonesia, malaria is highly prevalent in young children and is a significant cause of morbidity and early mortality. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Early and late mortality after malaria in young children in Papua, Indonesia
  5. 5
    “...A cross-sectional household survey was conducted in southern Papua, Indonesia, using cluster random sampling. Data were recorded using a standardized questionnaire. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
  6. 6
    “...METHODS: We prospectively enrolled patients hospitalized in Timika, Indonesia, with a Glasgow Coma Score (GCS) ≤10 and P. vivax monoinfection on initial microscopy over a four year period. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Coma Associated with Microscopy-Diagnosed Plasmodium vivax: A Prospective Study in Papua, Indonesia
  7. 7
    “...CONCLUSIONS: In Papua, Indonesia, malaria is a major cause of hospital presentation and admission in early life. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
  8. 8
    “...We used routinely collected patient data to compare the overall morbidity and mortality in patients treated with and without PQ without prior testing of Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency in Papua, Indonesia, where there is a low prevalence of G6PD deficiency. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
  9. 9
    “...In March 2006, antimalarial policy in Indonesia was changed to a unified treatment with dihydroartemisinin-piperaquine for all species of malaria because of the low efficacy of previous drug treatments. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Treatment-Seeking Behavior after the Implementation of a Unified Policy of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Papua, Indonesia
  10. 10
    “...Our aim was to investigate predictors of microbiological response to PTB treatment at the Tuberculosis Clinic in Timika, Papua Province, Indonesia and specifically, to determine the contribution of ethnicity. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Tuberculosis Outcomes in Papua, Indonesia: The Relationship with Different Body Mass Index Characteristics between Papuan and Non-Papuan Ethnic Groups
  11. 11
    “...Dihydroartemisinin–piperaquine (DHP) has been the first-line treatment of uncomplicated malaria due to both Plasmodium falciparum and Plasmodium vivax infections in Papua, Indonesia, since March 2006. The efficacy of DHP was reassessed to determine whether there had been any decline following almost a decade of its extensive use. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Therapeutic Response to Dihydroartemisinin–Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia
  12. 12
    “...In this study from Aceh Province, Indonesia, a malaria elimination setting where P. knowlesi endemicity was not previously known, we report the laboratory investigation and difficulties encountered when using molecular detection methods for quality assurance of microscopically identified clinical cases. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Laboratory challenges of Plasmodium species identification in Aceh Province, Indonesia, a malaria elimination setting with newly discovered P. knowlesi
  13. 13
    “...We investigated temporal trends in malaria-related morbidity and mortality in Papua, Indonesia, before and after introduction of a universal, artemisinin-based antimalarial treatment strategy for all Plasmodium species. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
  14. 14
    “...The study was conducted in Papua Indonesia, where high-grade chloroquine resistance in P. falciparum and P. vivax led to a universal policy of Artemisinin-based Combination Therapy (ACT) in 2006. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
  15. 15
    “...After reports of high levels of multidrug resistant P. falciparum and P. vivax in Indonesia, in 2005, the national first-line treatment policy for uncomplicated malaria was changed in March 2006, to dihydroartemisinin-piperaquine against all species. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
  16. 16
    “...We analyzed data from a randomized controlled trial in northwestern Thailand and 2 trials in Papua, Indonesia, to identify and compare risk factors for vivax gametocytemia at enrollment and following treatment. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
  17. 17
    “...BACKGROUND: Treatment failure of chloroquine for P. vivax infections has reached high levels in the eastern provinces of Indonesia, however, in vitro characterization of chloroquine resistance and its associated molecular profile have yet to be determined. ...”
    Testo
    Testo
    Testo
    testo
    Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms
  18. 18
    “...We describe a case of severe P. vivax malaria with hypotension, prostration, and acute kidney injury occurring 2 months after splenectomy in Papua, Indonesia. The patient was treated successfully with intravenous artesunate....”
    Testo
    Testo
    Testo
    Online Articolo testo
    Case Report: Severe Plasmodium vivax Malaria after Splenectomy
  19. 19
    “...CONCLUSIONS/SIGNIFICANCE: Plasmodium malariae infection is relatively uncommon in Papua, Indonesia but is associated with significant morbidity from anemia and a similar risk of mortality to patients hospitalized with P. falciparum and P. vivax infection. ...”
    Testo
    Testo
    Testo
    Online Articolo testo
    Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
  20. 20
    “...CONCLUSIONS: Unsupervised primaquine for vivax malaria, prescribed according to the current World Health Organization guidelines, was associated with a minimal reduction in the risk of clinical recurrence within 1 year in Papua, Indonesia. New strategies for the effective radical cure of vivax malaria are needed in resource-poor settings....”
    Testo
    Testo
    Testo
    Online Articolo testo
    Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
Strumenti per la ricerca: Feed RSS